MATINAS BIOPHARMA HOLDINGS, INC. Accounts Payable and Other Accrued Liabilities, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Accounts Payable and Other Accrued Liabilities, Current of $1.04 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2024-11-13
- 2024-09-30: Accounts Payable and Other Accrued Liabilities, Current $1.04M.
- 2024-06-30: Accounts Payable and Other Accrued Liabilities, Current $1.44M.
- 2024-03-31: Accounts Payable and Other Accrued Liabilities, Current $839.00K.
- 2023-12-31: Accounts Payable and Other Accrued Liabilities, Current $1.45M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.44M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $839.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.45M 10-Q · filed 2024-11-13 |
| 2023-09-30 | $1.76M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.37M 10-Q · filed 2023-08-09 |
| 2022-12-31 | $3.10M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |